Morgan Stanley & Co. LLC Rule 38.5 - ALLERGAN PLC (4409T)

TIDM0Y7T

RNS Number : 4409T

Morgan Stanley & Co. LLC

14 November 2019

FORM 38.5

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 38.5 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)

DEALINGS BY CONNECTED EXEMPT MARKET-MAKERS

   1.             KEY INFORMATION 
 
 Name of exempt market-maker            Morgan Stanley & Co. LLC 
 Company dealt in                       ALLERGAN PLC 
                                      -------------------------- 
 Class of relevant security to         US$0.0001 ORDINARY SHARES 
  which the dealings being disclosed 
  relate (Note 1) 
                                      -------------------------- 
 Date of dealing                        13 NOVEMBER 2019 
                                      -------------------------- 
 
   2.             DEALINGS (Note 2) 
   (a)           Purchases and sales 
 
 Total number of relevant   Highest price paid   Lowest price paid (Note 
  secuities accquired        (Note 3)             3) 
 236,782                    182.6700 USD         181.1600 USD 
                           -------------------  ------------------------ 
 
 
 Total number of relevant   Highest price paid   Lowest price paid (Note 
  secuities disposed         (Note 3)             3) 
 226,755                    182.6700 USD         181.1600 USD 
                           -------------------  ------------------------ 
 
   (b)           Derivatives transactions (other than options transactions) 
 
 Product name,   Nature of transaction   Number of relevant   Price per unit 
  e.g. CFD        (Note 4)                securities 
                                          (Note 5) 
 N/A             N/A                     N/A                  N/A 
                ----------------------  -------------------  --------------- 
 
   (c)            Options transactions in respect of existing relevant securities 
   i)           Writing, selling, purchasing or varying 
 
 Product         Writing,        Number           Exercise   Type, e.g    Expiry       Option 
  name, eg        selling,        of securities    Price      American,    Date         money paid/received 
  call option     purchasing,     to which                    European                  per unit 
                  varying         the option                  etc                       (Note 3) 
                  etc             relates 
                                  (Note 5) 
                                                                                       0.1300 
 PUT             PURCHASE        100              175.0000  A             15/11/2019    USD 
                --------------  ---------------  ---------  -----------  -----------  --------------------- 
                                                                                       1.6300 
 CALL            SALE            500              200.0000  A             15/05/2020    USD 
                --------------  ---------------  ---------  -----------  -----------  --------------------- 
 

(ii) Exercising

 
 Product name, eg call   Number of securities   Exercise price per 
  option                                         unit (Note 3) 
 N/A                     N/A                    N/A 
                        ---------------------  ------------------- 
 

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

 
 Full Details of any agreement, arrangement or understanding between 
  the person disclosing and any other person relating to the voting 
  rights of any relevant securities under any option referred to 
  on this form or relating to the voting rights or future acquisition 
  or disposal of any relevant securities to which any derivative 
  referred to on this form is referenced. If none, this should 
  be stated. 
 
 
 
 Date of disclosure              14 NOVEMBER 2019 
 Contact Name                   Craig Horsley 
                                ----------------- 
 Telephone Number               [phone] 
                                ----------------- 
 Name of offeree/offeror with   ABBVIE INC. 
  which connected 
                                ----------------- 
Nature of connection (Note 6)   Advisory 
                                ----------------- 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

END

ISELLFEILDLSLIA

(END) Dow Jones Newswires

November 14, 2019 06:00 ET (11:00 GMT)